Tue. Sep 17th, 2019

Policy Brief on Rota Virus Vaccine Project

Policy Brief on Rota Virus Vaccine Project

In many countries, rotavirus vaccination is the most cost-effective way to prevent rotavirus diarrhea. With this in
mind, the Essential Medicines and Technology Division (EMTD) in collaboration with Health Intervention
Technology Assessment Program (HITAP), Mahidol Oxford Research Unit (MORU), and PATH conducted a study
to assess the cost-effectiveness, budget impact, and human resource impact of a rotavirus vaccination program
compared with no vaccination.

Click here to read more…